cis-Urocanic acid
CAS: 7699-35-6
Ref. 3D-HAA69935
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
Name:
cis-Urocanic acid
Synonyms:
- (2Z)-3-(1H-Imidazol-5-yl)-2-propenoic acid
- 2-Propenoic acid, 3-(1H-imidazol-5-yl)-, (2Z)-
- 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (Z)-
- 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (2Z)-
- Imidazole-4-acrylic acid, (Z)-
Description:
cis-Urocanic acid is an experimental drug that has been shown to have significant interactions with transcription-polymerase chain reactions in vitro. cis-Urocanic acid inhibits the growth of skin cancer cells after UVB irradiation. It also inhibits angiogenic factors, lymphocyte transformation, and uvb-induced urothelial carcinoma cell proliferation. cis-Urocanic acid may be a useful treatment for skin cancer and uvb-induced urothelial carcinoma due to its inhibition of transcription-polymerase chain reactions and cell proliferation.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
138.12 g/mol
Formula:
C6H6N2O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
